Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice.

Aluganti Narasimhulu C, Mitra C, Bhardwaj D, Burge KY, Parthasarathy S.

J Alzheimers Dis. 2019 Jan 28. doi: 10.3233/JAD-180883. [Epub ahead of print]

PMID:
30714958
2.

Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Cervellati C, Valacchi G, Tisato V, Zuliani G, Marsillach J.

Minerva Med. 2018 Oct 11. doi: 10.23736/S0026-4806.18.05875-5. [Epub ahead of print]

PMID:
30334443
3.

PON1 DNA methylation and neurobehavior in Mexican-American children with prenatal organophosphate exposure.

Huen K, Solomon O, Kogut K, Eskenazi B, Holland N.

Environ Int. 2018 Dec;121(Pt 1):31-40. doi: 10.1016/j.envint.2018.08.044. Epub 2018 Aug 30.

4.

A review of biomarkers of Alzheimer's disease in noninvasive samples.

Hartmann S, Ledur Kist TB.

Biomark Med. 2018 Jun;12(6):677-690. doi: 10.2217/bmm-2017-0388. Epub 2018 Jun 13.

PMID:
29896987
5.

A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease.

Nie Y, Luo D, Yang M, Wang Y, Xiong L, Gao L, Liu Y, Liu H.

J Geriatr Psychiatry Neurol. 2017 Nov;30(6):303-310. doi: 10.1177/0891988717731825. Epub 2017 Sep 27. Review.

PMID:
28954597
6.

Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms.

Saeidi M, Shakeri R, Marjani A, Khajeniazi S.

Open Biochem J. 2017 Jun 13;11:47-55. doi: 10.2174/1874091X01711010047. eCollection 2017.

7.

The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients.

Arslan A, Tüzün FA, Arslan H, Demir H, Tamer S, Demir C, Tasin M.

Neurol Neurochir Pol. 2016 Nov - Dec;50(6):403-409. doi: 10.1016/j.pjnns.2016.07.002. Epub 2016 Jul 26.

PMID:
27546893
8.

Profile of the Paraoxonase 1 (PON1) Gene 192Q/R Polymorphism and Clinical Associations among Older Singaporean Chinese with Alzheimer's and Mixed Dementia.

Seow DC, Gao Q, Yap P, Gan JM, Chionh HL, Lim SC, Feng L, Ng TP.

Dement Geriatr Cogn Dis Extra. 2016 Feb 17;6(1):43-54. doi: 10.1159/000442382. eCollection 2016 Jan-Apr.

9.

Homocysteine metabolism and the associations of global DNA methylation with selected gene polymorphisms and nutritional factors in patients with dementia.

Bednarska-Makaruk M, Graban A, Sobczyńska-Malefora A, Harrington DJ, Mitchell M, Voong K, Dai L, Łojkowska W, Bochyńska A, Ryglewicz D, Wiśniewska A, Wehr H.

Exp Gerontol. 2016 Aug;81:83-91. doi: 10.1016/j.exger.2016.05.002. Epub 2016 May 7.

PMID:
27167582
10.

Effects of simvastatin on malondialdehyde level and esterase activity in plasma and tissue of normolipidemic rats.

Macan M, Vukšić A, Žunec S, Konjevoda P, Lovrić J, Kelava M, Štambuk N, Vrkić N, Bradamante V.

Pharmacol Rep. 2015 Oct;67(5):907-13. doi: 10.1016/j.pharep.2015.02.005. Epub 2015 Feb 26.

PMID:
26398384
11.

Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.

Cervellati C, Trentini A, Romani A, Bellini T, Bosi C, Ortolani B, Zurlo A, Passaro A, Seripa D, Zuliani G.

J Neurochem. 2015 Oct;135(2):395-401. doi: 10.1111/jnc.13240. Epub 2015 Aug 3.

12.

Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.

Bacchetti T, Vignini A, Giulietti A, Nanetti L, Provinciali L, Luzzi S, Mazzanti L, Ferretti G.

J Alzheimers Dis. 2015;46(1):179-86. doi: 10.3233/JAD-143096. Erratum in: J Alzheimers Dis. 2015;47(1):271.

PMID:
25720407
13.

Inflammation, infection, cancer and all that…the role of paraoxonases.

Devarajan A, Shih D, Reddy ST.

Adv Exp Med Biol. 2014;824:33-41. doi: 10.1007/978-3-319-07320-0_5. Review.

14.

Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer's disease and vascular dementia.

Alam R, Tripathi M, Mansoori N, Parveen S, Luthra K, Lakshmy R, Sharma S, Arulselvi S, Mukhopadhyay AK.

Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):769-76. doi: 10.1177/1533317514539541. Epub 2014 Jun 24.

PMID:
24965284
15.

Inactivation of the paraoxonase 1 gene affects the expression of mouse brain proteins involved in neurodegeneration.

Suszyńska-Zajczyk J, Luczak M, Marczak L, Jakubowski H.

J Alzheimers Dis. 2014;42(1):247-60. doi: 10.3233/JAD-132714.

PMID:
24844689
16.

Gene expression and functional annotation of the human and mouse choroid plexus epithelium.

Janssen SF, van der Spek SJ, Ten Brink JB, Essing AH, Gorgels TG, van der Spek PJ, Jansonius NM, Bergen AA.

PLoS One. 2013 Dec 31;8(12):e83345. doi: 10.1371/journal.pone.0083345. eCollection 2013.

17.

Paraoxonase 1 in neurological disorders.

Menini T, Gugliucci A.

Redox Rep. 2014 Mar;19(2):49-58. doi: 10.1179/1351000213Y.0000000071. Epub 2013 Nov 12. Review.

PMID:
24225313
18.

Paraoxonase 1 (PON1) gene-108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia.

Bednarska-Makaruk ME, Krzywkowski T, Graban A, Lipczyńska-Łojkowska W, Bochyńska A, Rodo M, Wehr H, Ryglewicz DK.

Folia Neuropathol. 2013;51(2):111-9.

19.

Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients.

Eroglu M, Yilmaz N, Yalcinkaya S, Ay N, Aydin O, Sezer C.

Kaohsiung J Med Sci. 2013 Jul;29(7):368-73. doi: 10.1016/j.kjms.2012.11.004. Epub 2013 Jan 16.

20.

LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease.

Cagnin A, Leon A, Vianello D, Colavito D, Favaretto S, Zarantonello G, Stecca A, Ermani M, Zambon A.

J Alzheimers Dis. 2013;34(2):377-85. doi: 10.3233/JAD-121717.

PMID:
23207490

Supplemental Content

Loading ...
Support Center